Stockreport

NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Neuropace, Inc.  (NPCE) 
PDF MOUNTAIN VIEW, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living wi [Read more]